The function of LncRNA-ATB in cancer
Amir Anbiyaiee, Mohammad Ramazii, Siamak Soltani Bajestani, Seyed Mohammadmahdi Meybodi, Mona Keivan, Seyed Esmaeil Khoshnam, Maryam Farzaneh
págs. 1-9
BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it
Ioannis Tsamis, G. Gomatou, Stavroula Porfyria Chachali, I. P. Trontzas, Vasileios Patriarcheas, E. Panagiotou, E. Kotteas
págs. 10-20
LncRNA MALAT1-related signaling pathways in osteosarcoma
Maryam Farzaneh, Sajad Najafi, Omid Anbiayee, S. Azizidoost, Seyed Esmaeil Khoshnam
págs. 21-32
The role of LncRNA MCM3AP-AS1 in human cancer
S. Azizidoost, Farhoodeh Ghaedrahmati, Mohadeseh Sheykhi-Sabzehpoush, Shahab Uddin, Mehri Ghafourian, Abdolah Mousavi Salehi, Mona Keivan, Maryam Cheraghzadeh, Zahra Nazeri, Maryam Farzaneh, Seyed Esmaeil Khoshnam
págs. 33-47
Functional roles of long noncoding RNA MALAT1 in gynecologic cancers
Maryam Farzaneh, Sajad Najafi, Mahrokh Abouali Gale Dari, Mohadeseh Sheykhi-Sabzehpoush, Diyan Dayer, Maryam Cheraghzadeh, S. Azizidoost
págs. 48-65
págs. 66-77
Nanoimmunoengineering strategies in cancer diagnosis and therapy
Robabehbeygom Ghafelehbashi, Melina Farshbafnadi, Niloofar Shokraneh Aghdam, Shahin Amiri, Mitra Salehi, Sepideh Razi
págs. 78-90
págs. 91-104
A research review of experimental animal models with myelodysplastic syndrome
Gen-Wang Chen, Mei-Na Chen, Lei Liu, Yu-Yu Zheng, Jin-Peng Wang, Si-Si Gong, Rong-Fu Huang, Chun-Mei Fan, Yue-Zu Chen
págs. 105-113
Application of tumor-educated platelets as new fluid biopsy markers in various tumors
Yuhan Wang, Humin Zhang, Huang Li, Jie Xiong, Jie Wang, Yuanshuai Huang
págs. 114-125
págs. 126-136
The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease
Juan Lu, Danhua Zhu, Xiaoqian Zhang, Jie Wang, Hongcui Cao, Lanjuan Li
págs. 137-150
Physicians’ attitudes and perceived barriers to adherence to the national breast cancer clinical practice guidelines in Mexico: a survey study
Bertha Alejandra Martinez Cannon, Enrique Soto Pérez de Celis, Aura Erazo Valle-Solís, Claudia Arce Salinas, Enrique Bargalló Rocha, Verónica Bautista Piña, Guadalupe Cervantes Sanchez, Christian Haydeé Flores Balcázar, Maria del Carmen Lara Tamburrino, Ana Lluch Hernández, Antonio Maffuz Aziz, Víctor Pérez Sánchez, María Adela C. Poitevin Chacón, Efraín Salas González, Laura Torrecillas Torres, Vicente Valero, Yolanda Villaseñor Navarro, Jesús Cárdenas Sánchez
págs. 151-159
págs. 160-172
Tumor mutational burden and efficacy of chemotherapy in lung cancer
Juan Song, Yu Yan, Cuicui Chen, Jiamin Li, Ning Ding, Nuo Xu, Hairong Bao, Xin Zhang, Qunying Hong, Jian Zhou, Yang W. Shao, Yuanlin Song, Lin Tong, Jie Hu
págs. 173-184
Reza Hosseini, Leila Asef-Kabiri, Hamzeh Sarvnaz, Alireza Ghanavatinejad, Fatemeh Rezayat, N. Eskandari, Mohammad Esmaeil Akbari
págs. 185-198
Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study
M. Stefanovic, Gemma Calvet, Héctor Pérez Montero, Anna Esteve Gómez, Montse Ventura, Arturo Navarro Martín, María Dolores Arnaiz Fernández, Ferran Ferrer González, Susanna Marín i Borràs, Alicia Lozano, Miriam Núñez Fernández, Miquel Maciá i Garau, Anna Lucas Calduch, Ferrán Guedea Edo
págs. 199-206
Senbang Yao, He Zuo, Wen Li, Yinlian Cai, Qianqian Zhang, Lulian Pang, Yanyan Jing, Xiangxiang Yin, Huaidong Cheng
págs. 207-217
DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer
Yuan Li, Leen Liao, Lingheng Kong, Wu Jiang, Jinghua Tang, Kai Han, Zhenlin Hou, Chenzhi Zhang, Chi Zhou, Linjie Zhang, Qiaoqi Sui, Binyi Xiao, Weijian Mei, Yanbo Xu, Jiehai Yu, Zhigang Hong, Zhizhong Pan, Peirong Ding
págs. 218-225
págs. 226-235
Discontinuation of mechanical bowel preparation in advanced ovarian cancer surgery: an enhanced recovery after surgery (ERAS) initiative
José Luis Sánchez Iglesias, N.R. Gómez Hidalgo, Vicente Bebia Conesa, José Manuel Ramírez Rodríguez, María Asunción Pérez Benavente, Gregg Nelson, Antonio Gil Moreno
págs. 236-242
págs. 243-255
Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial
Yin Wang, Yuerong Lai, Hongyu Peng, Shumei Yan, Zhimin Liu, Chongjie Tong, Xin Huang
págs. 256-268
págs. 269-282
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study
Dolores Isla Casado, Enriqueta Felip Font, María Pilar Garrido López, Amelia Insa Mollá, Margarita Majem, Jordi Remón Masip, José Manuel Trigo Pérez, Javier de Castro Carpeño
págs. 283-291
© 2001-2025 Fundación Dialnet · Todos los derechos reservados